Ruth K. Fredericks

Neurology
4204 Clay St
Vicksburg, MS 39183

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

Double-Blind Phase III Randomized Trial of the Antiprogestin Agent Mifepristone in the Treatment of Unresectable Meningioma: SWOG S9005.

Double-Blind Phase III Randomized Trial of the Antiprogestin Agent Mifepristone in the Treatment of Unresectable Meningioma: SWOG S9005.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: November 04, 2015
Showing 1-1 of 1

Last Updated: 09/26/2026